Literature DB >> 34000244

Updated recommendations regarding the management of older patients with breast cancer: a joint paper from the European Society of Breast Cancer Specialists (EUSOMA) and the International Society of Geriatric Oncology (SIOG).

Laura Biganzoli1, Nicolò Matteo Luca Battisti2, Hans Wildiers3, Amelia McCartney4, Giuseppe Colloca5, Ian H Kunkler6, Maria-João Cardoso7, Kwok-Leung Cheung8, Nienke Aafke de Glas9, Rubina M Trimboli10, Beatriz Korc-Grodzicki11, Enrique Soto-Perez-de-Celis12, Antonio Ponti13, Janice Tsang14, Lorenza Marotti15, Karen Benn16, Matti S Aapro17, Etienne G C Brain18.   

Abstract

Breast cancer is increasingly prevalent in older adults and is a substantial part of routine oncology practice. However, management of breast cancer in this population is challenging because the disease is highly heterogeneous and there is insufficient evidence specific to older adults. Decision making should not be driven by age alone but should involve geriatric assessments plus careful consideration of life expectancy, competing risks of mortality, and patient preferences. A multidisciplinary taskforce, including members of the European Society of Breast Cancer Specialists and International Society of Geriatric Oncology, gathered to expand and update the previous 2012 evidence-based recommendations for the management of breast cancer in older individuals with the endorsement of the European Cancer Organisation. These guidelines were expanded to include chemotherapy toxicity prediction calculators, cultural and social considerations, surveillance imaging, genetic screening, gene expression profiles, neoadjuvant systemic treatment options, bone-modifying drugs, targeted therapies, and supportive care. Recommendations on geriatric assessment, ductal carcinoma in situ, screening, primary endocrine therapy, surgery, radiotherapy, adjuvant systemic therapy, and secondary breast cancer were updated.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Year:  2021        PMID: 34000244     DOI: 10.1016/S1470-2045(20)30741-5

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  13 in total

Review 1.  Neoadjuvant systemic therapy in geriatric breast cancer patients: a National Cancer Database (NCDB) analysis.

Authors:  Lauren Brown; Samer A Naffouje; Christine Sam; Christine Laronga; M Catherine Lee
Journal:  Breast Cancer Res Treat       Date:  2022-10-08       Impact factor: 4.624

2.  Systemic inflammation in older patients with breast cancer: the missing point in geriatric evaluations to sharpen survival prediction.

Authors:  Andrés Vargas; Katarzyna Holub; Albert Biete
Journal:  Clin Transl Oncol       Date:  2022-04-27       Impact factor: 3.340

3.  Metaplastic Matrix-Producing Carcinoma and Apocrine Lobular Carcinoma In Situ Associated with Microglandular Adenosis: A Unique Case Report.

Authors:  Nektarios Koufopoulos; Dionysios Dimas; Foteini Antoniadou; Kyparissia Sitara; Dimitrios Balalis; Ioannis Boutas; Alina Roxana Gouloumis; Adamantia Kontogeorgi; Lubna Khaldi
Journal:  Diagnostics (Basel)       Date:  2022-06-13

4.  Tackling the clinical complexity of breast cancer.

Authors:  Marco Vincenzo Lenti; Federico Sottotetti; Gino Roberto Corazza
Journal:  Drugs Context       Date:  2022-06-28

5.  How aging of the global population is changing oncology.

Authors:  Yan Fei Gu; Frank P Lin; Richard J Epstein
Journal:  Ecancermedicalscience       Date:  2021-12-13

Review 6.  Challenges in Geriatric Oncology-A Surgeon's Perspective.

Authors:  Ruth Parks; Kwok-Leung Cheung
Journal:  Curr Oncol       Date:  2022-01-29       Impact factor: 3.677

7.  Differences in treatment and survival of older patients with operable breast cancer between the United Kingdom and the Netherlands - A comparison of two national prospective longitudinal multi-centre cohort studies.

Authors:  Willeke G van der Plas-Krijgsman; Jenna L Morgan; Nienke A de Glas; Anna Z de Boer; Charlene L Martin; Geoffrey R Holmes; Susan E Ward; Tim Chater; Malcolm W Reed; Jos W S Merkus; Thijs van Dalen; Annelie J E Vulink; Leander van Gerven; Onno R Guicherit; Eugenie Linthorst-Niers; Titia E Lans; Esther Bastiaannet; Johanneke E A Portielje; Gerrit Jan Liefers; Lynda Wyld
Journal:  Eur J Cancer       Date:  2022-01-23       Impact factor: 9.162

8.  Discontinuation of adjuvant endocrine therapy and impact on quality of life and functional status in older patients with breast cancer.

Authors:  Annelieke A Lemij; Nienke A de Glas; Marloes G M Derks; Esther Bastiaannet; Jos W S Merkus; Titia E Lans; Carmen C van der Pol; Thijs van Dalen; Annelie J E Vulink; Leander van Gerven; Onno R Guicherit; Eugenie M H Linthorst-Niers; Frederiek van den Bos; Judith R Kroep; Gerrit Jan Liefers; Johanneke E A Portielje
Journal:  Breast Cancer Res Treat       Date:  2022-04-19       Impact factor: 4.624

9.  The Usefulness of Spectral Mammography in Surgical Planning of Breast Cancer Treatment-Analysis of 999 Patients with Primary Operable Breast Cancer.

Authors:  Andrzej Lorek; Katarzyna Steinhof-Radwańska; Anna Barczyk-Gutkowska; Wojciech Zarębski; Piotr Paleń; Karol Szyluk; Joanna Lorek; Anna Grażyńska; Paweł Niemiec; Iwona Gisterek
Journal:  Curr Oncol       Date:  2021-07-12       Impact factor: 3.677

Review 10.  Personalising therapy for early-stage oestrogen receptor-positive breast cancer in older women.

Authors:  Neil Carleton; Azadeh Nasrazadani; Kristine Gade; Sushil Beriwal; Parul N Barry; Adam M Brufsky; Rohit Bhargava; Wendie A Berg; Margarita L Zuley; G J van Londen; Oscar C Marroquin; Darcy L Thull; Phuong L Mai; Emilia J Diego; Michael T Lotze; Steffi Oesterreich; Priscilla F McAuliffe; Adrian V Lee
Journal:  Lancet Healthy Longev       Date:  2022-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.